Page last updated: 2024-08-24

fluorodeoxyglucose f18 and mefloquine

fluorodeoxyglucose f18 has been researched along with mefloquine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujii, H; Matsumoto, M; Morimoto, A; Nakamichi, K; Nakamura, T; Saijo, M; Ueno, H; Yukitake, M1
Hatanaka, KC; Hirotani, M; Kano, T; Matsushima, M; Minami, N; Nakamichi, K; Nonaka, T; Saijo, M; Sasaki, H; Sasamori, T; Sato, K; Shiga, T; Shimizu, Y; Shirai, S; Takahashi, I; Tanaka, S; Yabe, I1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and mefloquine

ArticleYear
[Ineffective mefloquine therapy in progressive multifocal leukoencephalopathy complicated with malignant lymphoma: finding and usefulness of susceptibility-weighted imaging].
    Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:10

    Topics: Disease Susceptibility; Female; Fluorodeoxyglucose F18; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, B-Cell; Mefloquine; Middle Aged; Positron-Emission Tomography; Treatment Failure

2013
Usefulness of 11C-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathy.
    Journal of neurology, 2014, Volume: 261, Issue:12

    Topics: Aged; Aged, 80 and over; Antimalarials; Brain; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Methionine; Middle Aged; Positron-Emission Tomography; Prognosis; Treatment Outcome

2014